GPR37L1 anticorps

N° du produit ABIN636877

Cet anticorps Lapin Polyclonal détecte spécifiquement GPR37L1 dans IHC (p). Il présente une réactivité avec des échantillons de Humain.Il a été cité dans 1 publication.

Aperçu rapide pour GPR37L1 anticorps (ABIN636877)

Antigène: GPR37L1 (G Protein-Coupled Receptor 37 Like 1 (GPR37L1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GPR37L1 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-GPR37L1 anticorps

Purification: Affinity chromatography purified

Immunogène: GPR37 L1 antibody was raised in rabbit using a synthetic peptide conjugated to KLH as the immunogen.

Information d'application

Indications d'application: IHC-P: 10 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Purified by Immunoaffinity Chromatography and supplied in PBS with 0.1 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -70 °C for long term storage.

Références pour anticorps anti-GPR37L1 (ABIN636877)

Ehrenreich, Nau, Dembowski, Hasselblatt, Barth, Hahn, Schilling, Sirén A-L, Brück: "Endothelin b receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus." dans: Neuroscience, Vol. 95, Issue 4, pp. 993-1001, (2000) (PubMed).

Détails sur GPR37L1

Antigène: GPR37L1 (G Protein-Coupled Receptor 37 Like 1 (GPR37L1))

Autre désignation: GPR37L1

Sujet: Endothelin receptor type B is a G protein-coupled receptor which activates a phosphatidylinositol-calcium second messenger system. Its ligand, endothelin, consists of a family of three potent vasoactive peptides: ET1, ET2, and ET3. Two splice variants have been identified both of which bind ET1 but exhibit different responses upon binding which suggests that they may be functionally distinct.